---
title: "CPRX.US (CPRX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CPRX.US/news.md"
symbol: "CPRX.US"
name: "CPRX.US"
parent: "https://longbridge.com/en/quote/CPRX.US.md"
datetime: "2026-05-20T06:52:25.339Z"
locales:
  - [en](https://longbridge.com/en/quote/CPRX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CPRX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CPRX.US/news.md)
---

# CPRX.US (CPRX.US) — Related News

### [Are KALV, GBTG, MDV, CPRX Obtaining Fair Deals for their Shareholders?](https://longbridge.com/en/news/286973039.md)
*2026-05-19T22:22:00.000Z*
> Halper Sadeh LLC is investigating potential violations of federal securities laws and breaches of fiduciary duties relat

### [Angelini Buyout And Firdapse Settlement Reframe Catalyst Pharmaceuticals Story](https://longbridge.com/en/news/286669201.md)
*2026-05-17T10:12:05.000Z*
> Catalyst Pharmaceuticals (NasdaqCM: CPRX) has agreed to an all-cash acquisition by Angelini Pharma, settling Firdapse pa

### [02:56 ETAre CPRX, UNF, RMAX, ACR Obtaining Fair Deals for their Shareholders?](https://longbridge.com/en/news/286049381.md)
*2026-05-12T06:57:19.000Z*
> Halper Sadeh LLC is investigating Catalyst Pharmaceuticals, UniFirst Corporation, RE/MAX Holdings, and ACRES Commercial 

### [Key deals this week: Roche, Bayer, eBay, Bullish, and more](https://longbridge.com/en/news/285850316.md)
*2026-05-10T19:47:21.000Z*
> This week saw significant deals across various sectors. Two Harbors Investment amended its merger with CrossCountry Mort

### [Catalyst Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Catalyst Pharmaceuticals, Inc. - CPRX](https://longbridge.com/en/news/285824076.md)
*2026-05-10T00:34:13.000Z*
> Kahn Swick & Foti, LLC is investigating the proposed sale of Catalyst Pharmaceuticals, Inc. (CPRX) to Angelini Pharma S.

### [$4.1 billion, a rare disease company was acquired](https://longbridge.com/en/news/285805637.md)
*2026-05-09T08:52:25.000Z*
> Italian pharmaceutical company Angelini Pharma acquires the American rare disease company Catalyst for $4.1 billion, wit